Case report of anti-glomerular basement membrane disease following alemtuzumab treatment of relapsing-remitting multiple sclerosis

Multiple Sclerosis and Related Disorders

Volumn 2, Issue 1, 2013, Pages 60-63

  Meyer, David ^a   Coles, Alasdair ^b   Oyuela, Pedro ^c   Purvis, Annie ^c   Margolin, David H ^c  

^a Triad Neurological Associates   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c GENZYME CORPORATION   (United States)

Author keywords

Alemtuzumab; Anti glomerular basement membrane disease; Autoimmune disease; Goodpasture's syndrome; Multiple sclerosis; Pulmonary renal syndrome

Indexed keywords

ALEMTUZUMAB; CREATININE; CYCLOPHOSPHAMIDE; LEVOTHYROXINE; PREDNISONE;

ADULT; ADVERSE OUTCOME; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG TREATMENT FAILURE; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS; HUMAN; HYPOTHYROIDISM; IMMUNOFLUORESCENCE TEST; KIDNEY BIOPSY; KIDNEY FUNCTION TEST; LEUKOPENIA; MULTIPLE CYCLE TREATMENT; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; OUTPATIENT CARE; PLASMAPHERESIS;

EID: 84866686643     PISSN: 22110348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msard.2012.07.002     Document Type: Article

References (15)

1. D. Charytan, B. MacDonald, H. Sugimoto, S. Pastan, G. Staton, and R. Hennigar An unusual case of pulmonary-renal syndrome associated with defects in type IV collagen composition and anti-glomerular basement membrane autoantibodies. American Journal of Kidney Diseases 45 4 2005 743 748
2. M.R. Clatworthy, E.F. Wallin, and D.R. Jayne Anti-glomerular basement membrane disease after alemtuzumab New England Journal of Medicine 359 7 2008 768 769
3. Coles A. Alemtuzumab treatment benefit is durable: primary efficacy outcomes of CAMMS223 at 4 years. Presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis; Dusseldorf, Germany; 2009.
4. A.J. Coles, D.A. Compston, K.W. Selmaj, S.L. Lake, S. Moran, and D.H. Margolin Alemtuzumab vs. interferon beta-1a in early multiple sclerosis New England Journal of Medicine 359 17 2008 1786 1801
5. A.J. Coles, A. Cox, E. Le Page, J. Jones, S.A. Trip, and J. Deans The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy Journal of Neurology 253 1 2006 98 108
6. R.D. Henderson, C.J. Bain, and M.P. Pender The occurrence of autoimmune diseases in patients with multiple sclerosis and their families Journal of Clinical Neuroscience 7 5 2000 434 437
7. R.D. Henderson, D. Saltissi, and M.P. Pender Goodpasture's syndrome associated with multiple sclerosis Acta Neurologica Scandinavica 98 2 1998 134 135
8. J.L. Jones, C.L. Phuah, A.L. Cox, S.A. Thompson, M. Ban, and J. Shawcross IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H) Journal of Clinical Investigation 119 7 2009 2052 2061
9. J.B. Levy, and C.D. Pusey Anti-GBM antibody mediated disease J.R. Wilkinson R, Nephrology 1997 Chapman and Hall London 599 615
10. J.B. Levy, A.N. Turner, A.J. Rees, and C.D. Pusey Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression Annals of Internal Medicine 134 11 2001 1033 1042
11. C.M. Litwin, C.L. Mouritsen, P.A. Wilfahrt, M.C. Schroder, and HR. Hill Anti-glomerular basement membrane disease: role of enzyme-linked immunosorbent assays in diagnosis Biochemical and Molecular Medicine 59 1 1996 52 56
12. Meyer D, Coles A, on behalf of the CAMMS223 Study Group. Case report of anti-glomerular basement membrane disease following alemtuzumab treatment. Presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis; Gothenburg, Sweden; 2010.
13. J.D. Ooi, S.R. Holdsworth, and A.R. Kitching Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells Journal of Autoimmunity 31 3 2008 295 300
14. V. Pedchenko, O. Bondar, A.B. Fogo, R. Vanacore, P. Voziyan, and A.R. Kitching Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis New England Journal of Medicine 363 4 2010 343 354
15. R.A. Sinico, A. Radice, C. Corace, E. Sabadini, and B. Bollini Anti-glomerular basement membrane antibodies in the diagnosis of Goodpasture syndrome: a comparison of different assays Nephrology Dialysis Transplantation 21 2 2006 397 401